Rana Sugars P/E Ratio
Current P/E Ratio
39.62
High Valuation
Very High - High growth expectations or significantly overvalued
Rana Sugars (RANASUG) P/E ratio is 39.62 (High), EPS (TTM) ₹1.55, current price ₹14.43 on NSE — Very High - High growth expectations or significantly overvalued.
Current Valuation Metrics
P/E Ratio
39.62
Current Price
₹14.43
EPS (TTM)
₹1.55
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
48.65
Sector Median
25.5
Sector Rank
#11 of 286
Sector Percentile
3.8%
RANASUG P/E Ratio — Valuation Signal & Historical Context
Rana Sugars P/E 39.62 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Rana Sugars screener.
- Stock appears overvalued with PE of 39.62, suggesting caution for new investments
- Trading at discount to sector average PE of 48.65
RANASUG vs Consumer Goods Peers — P/E Ratio Comparison
Rana Sugars P/E 39.62 vs Consumer Goods average 48.65, median 25.5 — range 1.17–857.5.
Sector Average
48.65
Sector Median
25.5
Lowest P/E
1.17
Highest P/E
857.5
Companies
286
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Orosil Smiths | OROSMITHS | 1.17 | ₹29 | Low |
| Royal India Corp | ROYALIND | 1.23 | ₹67 | Low |
| Kabra Jewels | KKJEWELS | 4.09 | ₹101 | Low |
| Simbhaoli Sugars | SIMBHALS | 4.26 | ₹40 | Low |
| Indian Sucrose | INDSUCR | 4.4 | ₹130 | Low |
| Eighty Jewellers | EIGHTY | 4.4 | ₹43 | Low |
| Raghunath International | RAGHUNAT | 4.88 | ₹5 | Low |
| Deep Diamond | DDIL | 5.21 | ₹30 | Low |
| India Glycols | INDIAGLYCO | 5.28 | ₹1,768 | Low |
| Medistep Healthcare | MEDISTEP | 5.34 | ₹31 | Low |